Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
NPJ Genom Med ; 1: 15008, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-29263806

RESUMO

The announcement of the Precision Medicine Initiative was an important step towards establishing the use of genomic information as part of the wider practice of medicine. The US military has been exploring the role that genomic information will have in health care for service members (SMs) and its integration into the continuum of military medicine. An important part of the process is establishing robust protections to protect SMs from genetic discrimination in the era of exome/genome sequencing.

3.
BMC Microbiol ; 6: 8, 2006 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-16464252

RESUMO

BACKGROUND: It has been recently reported that major pathogens Staphylococcus aureus and Pseudomonas aeruginosa accelerate a normal process of cell surface syndecan-1 (Synd1) ectodomain shedding as a mechanism of host damage due to the production of shedding-inducing virulence factors. We tested if acceleration of Synd1 shedding takes place in vitro upon treatment of epithelial cells with B. anthracis hemolysins, as well as in vivo during anthrax infection in mice. RESULTS: The isolated anthrax hemolytic proteins AnlB (sphingomyelinase) and AnlO (cholesterol-binding pore-forming factor), as well as ClnA (B. cereus homolog of B. anthracis phosphatidyl choline-preferring phospholipase C) cause accelerated shedding of Synd1 and E-cadherin from epithelial cells and compromise epithelial barrier integrity within a few hours. In comparison with hemolysins in a similar range of concentrations, anthrax lethal toxin (LT) also accelerates shedding albeit at slower rate. Individual components of LT, lethal factor and protective antigen are inactive with regard to shedding. Inhibition experiments favor a hypothesis that activities of tested bacterial shedding inducers converge on the stimulation of cytoplasmic tyrosine kinases of the Syk family, ultimately leading to activation of cellular sheddase. Both LT and AnlO modulate ERK1/2 and p38 MAPK signaling pathways, while JNK pathway seems to be irrelevant to accelerated shedding. Accelerated shedding of Synd1 also takes place in DBA/2 mice challenged with Bacillus anthracis (Sterne) spores. Elevated levels of shed ectodomain are readily detectable in circulation after 24 h. CONCLUSION: The concerted acceleration of shedding by several virulence factors could represent a new pathogenic mechanism contributing to disruption of epithelial or endothelial integrity, hemorrhage, edema and abnormal cell signaling during anthrax infection.


Assuntos
Bacillus anthracis/metabolismo , Células Epiteliais/metabolismo , Células Epiteliais/microbiologia , Sindecana-1/metabolismo , Fatores de Virulência/metabolismo , Animais , Antígenos de Bactérias/metabolismo , Toxinas Bacterianas/metabolismo , Caderinas/metabolismo , Linhagem Celular , Proteínas Hemolisinas/metabolismo , Humanos , L-Lactato Desidrogenase/metabolismo , Camundongos , Camundongos Endogâmicos DBA , Esfingomielina Fosfodiesterase/metabolismo , Fosfolipases Tipo C/metabolismo
4.
Immunol Lett ; 91(2-3): 171-8, 2004 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-15019287

RESUMO

The effects of interleukine-15 (IL-15) on macrophage activation and antiviral activity have been investigated in this study. We have provided evidence that IL-15 stimulates murine macrophage RAW 264.7 cells to release nitric oxide (NO) and inhibit vaccinia virus (VV) replication in bystander human 293 cells in a dose-dependent manner. The IL-15-induced antiviral activity was partially mediated by NO, as blocking NO production by NO synthase (iNOS) inhibitor NG-monomethyl-L-arginine acetate (L-NMA) partially restored the virus replication. Interferon-gamma (IFN-gamma) was not detectable by ELISA in the cell supernatant of IL-15-activated macrophages or in the co-cultures of macrophages and infected bystander cells. Neutralizing anti-IFN-gamma, anti-IFN-gamma receptor R2, anti-TNF-alpha, or anti-IL-12 antibodies had no effect on NO production or antiviral activity. In contrast, neutralizing anti-IFN-alpha/beta antibody completely restored the VV replication and reduced the NO level to one third of that in the control. Elevated mRNA levels of IFN-beta and iNOS genes were detected in IL-15-activated RAW 264.7 cells by RT-PCR. Our data suggest that IL-15 is capable of inducing IFN-beta, which could participate in NO-mediated antiviral effect.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Interferon beta/genética , Interleucina-15/farmacologia , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Óxido Nítrico Sintase/genética , Animais , Efeito Espectador/efeitos dos fármacos , Linhagem Celular , Humanos , Interferon beta/análise , Interferon beta/antagonistas & inibidores , Interferon beta/imunologia , Interferon gama/análise , Interferon gama/genética , Interferon gama/farmacologia , Macrófagos/enzimologia , Macrófagos/metabolismo , Camundongos , Óxido Nítrico Sintase Tipo II , Óxidos de Nitrogênio/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Transcrição Gênica/efeitos dos fármacos , Fator de Necrose Tumoral alfa/metabolismo , Vaccinia virus/imunologia , Vaccinia virus/fisiologia , Replicação Viral/efeitos dos fármacos , ômega-N-Metilarginina/farmacologia
5.
Cell Microbiol ; 6(3): 225-33, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14764106

RESUMO

Systemic pro-inflammatory cytokine release has been previously implicated as a major death-causing factor in anthrax, however, direct data have been absent. We determined the levels of IL-1 beta, IL-6 and TNF-alpha in serum of mice challenged with virulent (Ames) or attenuated (Sterne) strains of Bacillus anthracis. More than 10-fold increase in the IL-1beta levels was detected in Ames-challenged Balb/c mice, in contrast to more susceptible C57BL/6 mice, which showed no IL-1beta response. Balb/c mice have also responded with higher levels of IL-6. The A/J mice demonstrated IL-1beta and IL-6 systemic response to either Ames or Sterne strain of B. anthracis, whereas no increase in TNF-alpha was detected in any murine strain. We used RT-PCR for gene expression analyses in the liver which often is a major source of cytokines and one of the main targets in infectious diseases. A/J mice challenged with B. anthracis (Sterne) showed increased gene expression for Fas, FasL, Bax, IL-1 beta, TNF-alpha, TGF-beta, MIP-1alpha, KC and RANTES. These data favour the hypothesis that apoptotic cell death during anthrax infection causes chemokine-induced transmigration of inflammatory cells to vitally important organs such as liver. Administration of caspase inhibitors z-VAD-fmk and ac-YVAD-cmk improved survival in Sterne-challenged mice indicating a pathogenic role of apoptosis in anthrax.


Assuntos
Antraz/imunologia , Bacillus anthracis , Citocinas/imunologia , Animais , Citocinas/análise , Camundongos , Camundongos Endogâmicos
6.
J Infect Dis ; 188(8): 1138-41, 2003 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-14551883

RESUMO

Anthrax toxin can induce hemolysis in the presence of polymorphonuclear cells (PMNs), an activity primarily mediated by protective antigen, with synergic effects provided by lethal factor and edema factor. Lethal factor and edema factor, individually or in combination, are incapable of lysing red blood cells. The requirement for the presence of PMNs indicates that hemolysis associated with Bacillus anthracis infection is indirect rather than direct, as observed in many other bacterial infections.


Assuntos
Antígenos de Bactérias , Toxinas Bacterianas/farmacologia , Hemólise/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Bacillus anthracis/metabolismo , Bacillus anthracis/patogenicidade , Hemoglobinas/análise , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA